Brief: 60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio
15/01/2026 13:11
Jan 15 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O: 60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO 60 DEGREES PHARMACEUTICALS INC - PHARMA ANNOUNCES 1:4 REVERSE STOCK SPLIT Source text: ID:nGNX2xys4v Further company coverage: SXTP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 60 Degrees Pharmaceuticals
See all newsBrief: 60 Degrees Pharmaceuticals Says May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028 - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM